Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms.
Mol Psychiatry
; 26(12): 7098-7099, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34385600
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sphingomyelin Phosphodiesterase
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Mol Psychiatry
Journal subject:
BIOLOGIA MOLECULAR
/
PSIQUIATRIA
Year:
2021
Type:
Article
Affiliation country:
France